Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

The Curious, Very Long Delay In A Pioneering Drug Prices Suit No Photo Available

Jeff Overley

When Merck & Co. launched a fiery challenge to Medicare's landmark drug price negotiations, it blazed a trail for many similar suits. ... (more story)

How NY Atty Helped Win 12-Year Fight Over Hospital Pricing No Photo Available

Daniel Connolly

When Matthew Cantor got involved in a sweeping antitrust case against California-based healthcare network Sutter Health, his youngest ... (more story)

NC Biz Court Bulletin: Trade Secrets Row, A Patient Data Deal No Photo Available

Hayley Fowler

The North Carolina Business Court closed out the year by tossing a trade secrets fight brought by a corrugated packing manufacturer ag... (more story)